ORLANDO, Fla., Oct. 18, 2018 /PRNewswire/ -- The Orthopaedic Implant Company ("OIC") launched its Semi-Extended Instrumentation for the OIC Tibial Nail from Gaylord Palms Convention Center in Orlando, Florida, at the 2018 Annual Meeting of the Orthopaedic Trauma Association (OTA).
"The OIC IM Nail System brings OR efficiency and value to a whole new level," said Itai Nemovicher, President and CEO of OIC. "The complete system is supported by a single set of instrumentation, flattening the surgical technique learning curve across a multitude of fracture patterns requiring intramedullary fixation."
Used in conjunction with the OIC Tibial Nail, the OIC Semi-Extended Instrumentation affords surgeons an alternate method for intramedullary nailing of the tibia. By allowing for less flexion of the knee during implantation, this approach may help avoid fracture malreductions and misalignment and improve imaging.
"We are pleased to continue to expand our line of implants to accommodate surgeon preferences comprehensively," said Todd Martens, Vice President of Product Design and Customer Experience. "The feedback on the Tibial nail itself has been incredibly positive. Adding the suprapatellar instrumentation was naturally the next step." When asked about future products, Mr. Martens said, "The product pipeline is full and we will be able to share some exciting developments soon."
For more information about The Orthopaedic Implant Company please visit www.orthoimplantcompany.com
About The Orthopedic Implant Company:
Not just another vendor, The Orthopedic Implant Company (OIC) is the leading high-value orthopedic trauma implant manufacturer whose mission is to offer the highest quality implants at the lowest possible prices. In doing so, OIC provides surgeons and facilities with the value they rely on to successfully meet the challenges of value-based care. OIC implants can be used for a variety of procedures, including treatment of orthopedic trauma and spinal injuries. All OIC products are FDA-approved and manufactured in FDA-approved facilities.
SOURCE The Orthopaedic Implant Company